# Cancer Chemotherapy and Pharmacology

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/cancer-chemotherapy-and-pharmacology/

## Facts

| Field | Value |
| --- | --- |
| Open Access | false |
| ISSN-L | 0344-5704 |
| ISSNs | 0344-5704,1432-0843 |
| OpenAlex ID | https://openalex.org/S117498271 |
| Publisher | Springer Science+Business Media |

## Journal papers

- [Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience](https://scholariq.org/papers/capecitabine-and-temozolomide-captem-for-metastatic-well-differentiated/)
- [Therapeutic drug monitoring of 5-fluorouracil](https://scholariq.org/papers/therapeutic-drug-monitoring-of-5-fluorouracil/)
- [A panel of serum exosomal microRNAs as predictive markers for chemoresistance in advanced colorectal cancer](https://scholariq.org/papers/a-panel-of-serum-exosomal-micrornas-as-predictive-markers-for-chemoresistance-in/)
- [Lysosomotropic acid ceramidase inhibitor induces apoptosis in prostate cancer cells](https://scholariq.org/papers/lysosomotropic-acid-ceramidase-inhibitor-induces-apoptosis-in-prostate-cancer/)
- [Population pharmacokinetics of bevacizumab in cancer patients with external validation](https://scholariq.org/papers/population-pharmacokinetics-of-bevacizumab-in-cancer-patients-with-external/)
- [Oxymatrine targets EGFRp-Tyr845 and inhibits EGFR-related signaling pathways to suppress the proliferation and invasion of gastric cancer cells](https://scholariq.org/papers/oxymatrine-targets-egfrp-tyr845-and-inhibits-egfr-related-signaling-pathways-to/)
- [Pharmacokinetics of ecteinascidin 743 administered as a 24-h continuous intravenous infusion to adult patients with soft tissue sarcomas: associations with clinical characteristics, pathophysiological variables and toxicity](https://scholariq.org/papers/pharmacokinetics-of-ecteinascidin-743-administered-as-a-24-h-continuous/)
- [Asparaginase Erwinia chrysanthemi effectively depletes plasma glutamine in adult patients with relapsed/refractory acute myeloid leukemia](https://scholariq.org/papers/asparaginase-erwinia-chrysanthemi-effectively-depletes-plasma-glutamine-in-adult/)
- [The prognostic value of CA19-9 response after neoadjuvant therapy in patients with pancreatic cancer: a systematic review and pooled analysis](https://scholariq.org/papers/the-prognostic-value-of-ca19-9-response-after-neoadjuvant-therapy-in-patients/)
- [Tolerance, variability, and pharmacokinetics of bevacizumab biosimilars in Chinese healthy male subjects](https://scholariq.org/papers/tolerance-variability-and-pharmacokinetics-of-bevacizumab-biosimilars-in-chinese/)
- [Concordance between the response evaluation criteria in solid tumors version 1.1 and the immune-related response criteria in patients with non-small cell lung cancer treated with nivolumab: a multicenter retrospective cohort study](https://scholariq.org/papers/concordance-between-the-response-evaluation-criteria-in-solid-tumors-version-1-1/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.